BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26366889)

  • 1. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
    Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure.
    Yanagida R; Czer LS; Ruzza A; Schwarz ER; Simsir SA; Jordan SC; Trento A
    Transplant Proc; 2013; 45(6):2378-83. PubMed ID: 23953551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
    Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular assist device as a bridge to heart transplantation in children.
    Januszewska K; Malec E; Birnbaum J; Loeff M; Sodian R; Schmitz C; Netz H; Reichart B
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):807-10. PubMed ID: 19666650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes.
    Baldwin AC; Sandoval E; Letsou GV; Mallidi HR; Cohn WE; Frazier OH
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):192-8. PubMed ID: 26344685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular Assist Device Driveline Infections: A Systematic Review.
    Krzelj K; Petricevic M; Gasparovic H; Biocina B; McGiffin D
    Thorac Cardiovasc Surg; 2022 Sep; 70(6):493-504. PubMed ID: 34521143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Treatment for Percutaneous Sites in Patients with a Ventricular Assist Device: Nihon University Crystal Violet Method.
    Sezai A; Niino T; Osaka S; Yaoita H; Arimoto M; Hata H; Shiono M
    Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):246-50. PubMed ID: 27086670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation.
    Gaffey AC; Phillips EC; Howard J; Hung G; Han J; Emery R; Goldberg L; Acker MA; Woo YJ; Atluri P
    Ann Thorac Surg; 2015 Aug; 100(2):542-9. PubMed ID: 26070597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis.
    Murray LK; González-Costello J; Jonas SN; Sims DB; Morrison KA; Colombo PC; Mancini DM; Restaino SW; Joye E; Horn E; Takayama H; Marboe CC; Naka Y; Jorde UP; Uriel N
    Eur J Heart Fail; 2012 Mar; 14(3):312-8. PubMed ID: 22265922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.